Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
The characterization of human hematopoietic stem cells (HSCs) will facilitate the hematopoietic cell therapy such as bone marrow transplantation. Although the human HSCs have been identified by the expression of distinct surface markers, we have identified a microRNA, miR-126, is highly expressed and has an important role in human HSCs. We have developed a new system, which allows us to identify the cells with miR-126 expression and found a new population that might have a new hematopoietic stem cell activity. Further characterization of this population is under investigation.
|